Severe alterations in lipid composition of frontal cortex lipid rafts from parkinson's disease and incidental parkinson's

dc.contributor.author
Fabelo, Noemí
dc.contributor.author
Martín, Virginia
dc.contributor.author
Santpere Baró, Gabriel
dc.contributor.author
Marín, Raquel
dc.contributor.author
Torrent, Laia
dc.contributor.author
Ferrer, Isidro (Ferrer Abizanda)
dc.contributor.author
Díaz, Mario
dc.date.issued
2019-01-25T15:18:45Z
dc.date.issued
2019-01-25T15:18:45Z
dc.date.issued
2010
dc.date.issued
2019-01-25T15:18:45Z
dc.identifier
1076-1551
dc.identifier
https://hdl.handle.net/2445/127630
dc.identifier
600983
dc.identifier
21717034
dc.description.abstract
Lipid rafts are cholesterol- and sphingomyelin-enriched microdomains that provide a highly saturated and viscous physicochemical microenvironment to promote protein-lipid and protein-protein interactions. We purified lipid rafts from human frontal cortex from normal, early motor stages of Parkinson's disease (PD) and incidental Parkinson's disease (iPD) subjects and analyzed their lipid composition. We observed that lipid rafts from PD and iPD cortices exhibit dramatic reductions in their contents of n-3 and n-6 long-chain polyunsaturated fatty acids, especially docosahexaenoic acid (22:6-n3) and arachidonic acid (20:4n-6). Also, saturated fatty acids (16:0 and 18:0) were significantly higher than in control brains. Paralleling these findings, unsaturation and peroxidability indices were considerably reduced in PD and iPD lipid rafts. Lipid classes were also affected in PD and iPD lipid rafts. Thus, phosphatidylserine and phosphatidylinositol were increased in PD and iPD, whereas cerebrosides and sulfatides and plasmalogen levels were considerably diminished. Our data pinpoint a dramatic increase in lipid raft order due to the aberrant biochemical structure in PD and iPD and indicate that these abnormalities of lipid rafts in the frontal cortex occur at early stages of PD pathology. The findings correlate with abnormal lipid raft signaling and cognitive decline observed during the development of these neurodegenerative disorders.
dc.format
12 p.
dc.format
application/pdf
dc.language
eng
dc.publisher
BioMed Central
dc.relation
Reproducció del document publicat a: https://doi.org/10.2119/molmed.2011.00119
dc.relation
Molecular Medicine, 2010, vol. 17, num. 9-10, p. 1107-1118
dc.relation
https://doi.org/10.2119/molmed.2011.00119
dc.rights
(c) Molecular Medicine, 2010
dc.rights
info:eu-repo/semantics/openAccess
dc.source
Articles publicats en revistes (Patologia i Terapèutica Experimental)
dc.subject
Malaltia de Parkinson
dc.subject
Colesterol
dc.subject
Parkinson's disease
dc.subject
Cholesterol
dc.title
Severe alterations in lipid composition of frontal cortex lipid rafts from parkinson's disease and incidental parkinson's
dc.type
info:eu-repo/semantics/article
dc.type
info:eu-repo/semantics/publishedVersion


Ficheros en el ítem

FicherosTamañoFormatoVer

No hay ficheros asociados a este ítem.